The LeAAPS Trial is a pivotal initiative intended to evaluate the safety and effectiveness of surgical LAA exclusion to prevent stroke in patients with an elevated risk, but no history of Afib.
Learn more about the groundbreaking study: <a href="https://t.co/axe7Ec8Vdn" target="_blank">https://t.co/axe7Ec8Vdn</a>
<a href="https://twitter.com/hashtag/ClinicalTrial?src=hashtag_click" target="_blank">#ClinicalTrial</a>
- Healthcare Professionals
- Therapies and Procedures
- Concomitant Surgical Ablation Therapy
- Ablation Sensing Unit & Switch Matrix
- cryoFORM® Cryoablation Probe
- cryoICE® BOX V6
- cryoICE® Cryoablation Probes
- Isolator® Linear Pen
- Isolator® Synergy™ Access® Clamp
- Isolator® Synergy™ Clamps (OLL2/OSL2)
- Isolator® Transpolar Pen (MAX3)
- Isolator® Synergy™ EnCompass® Clamp
- Multifunctional Ablation Generator (MAG)
- Hybrid AF™ Therapy
- Hybrid Total Thoracoscopic Therapy
- Left Atrial Appendage Management
- Cryo Nerve Block Therapy
- Concomitant Surgical Ablation Therapy
- Education & Training
- Clinical Evidence
- Product Labeling
- Resources
- Society Guidelines
- Therapies and Procedures
- Patients & Caregivers
- About AtriCure